Active Biotech
web2Active Biotech is a Swedish biotechnology company developing experimental medicines for blood c...
About
Active Biotech is a Swedish biotechnology company developing experimental medicines for blood cancers and inflammatory eye diseases, with clinical programs based on immunomodulation and targeted cancer treatment. Its lead candidate, tasquinimod, is being studied for myelofibrosis, a disorder affecting blood cell production in the bone marrow. The company is also developing laquinimod as an eye-drop treatment for inflammatory conditions such as noninfectious uveitis. Naptumomab, an investigational cancer immunotherapy for solid tumors, is licensed to a development partner. Active Biotech conducts development with clinical research collaborators rather than selling approved medicines from these programs.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Active Biotech profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy